Investor profile
Frazier Life Sciences has backed 2 European tech companies across 2 funding rounds between 2022 and 2025, joining rounds totalling €435M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 1 | €308M |
| Vectivbio | Switzerland | 1 | €127M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Vectivbio | Other | €127M | 2022-10 |
